VNDA - Vanda Pharmaceuticals drops after Future Pak walks away
2024-06-27 08:44:55 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals: Undervalued With Promising Pipeline And Acquisition Interest
- Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript
- Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
- Vanda slips after rejecting takeover offers
- Vanda Pharmaceuticals gains as Future Pak raises offer to $8.50-$9 a share (update)